CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
President Trump's government overhaul in annual reports, highlighting risks from tariffs to healthcare reforms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback